As VEGF is a vital factor for angiogenesis across various organs, and the same isoform of VEGF has been detected in the brain and eyes in animal experiments (Ng et al., 2001), concerns have arisen about whether using anti‐VEGF to treat ROP might also affect nervous system development. The gene discussed is VEGFA; the disease is retinopathy of prematurity.